These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7972237

  • 1. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
    Hiemstra JL, Schneider SS, Brodeur GM.
    Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237
    [Abstract] [Full Text] [Related]

  • 2. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.
    Reiter JL, Brodeur GM.
    Genomics; 1996 Feb 15; 32(1):97-103. PubMed ID: 8786126
    [Abstract] [Full Text] [Related]

  • 3. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
    Schneider SS, Zehnbauer BA, Vogelstein B, Brodeur GM.
    Prog Clin Biol Res; 1991 Feb 15; 366():71-6. PubMed ID: 2068181
    [Abstract] [Full Text] [Related]

  • 4. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
    Amler LC, Schwab M.
    Oncogene; 1992 Apr 15; 7(4):807-9. PubMed ID: 1565478
    [Abstract] [Full Text] [Related]

  • 5. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
    Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt F, Latt SA.
    Cancer Res; 1986 Oct 15; 46(10):5297-301. PubMed ID: 3756879
    [Abstract] [Full Text] [Related]

  • 6. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
    Kuroda H, White PS, Sulman EP, Manohar CF, Reiter JL, Cohn SL, Brodeur GM.
    Oncogene; 1996 Oct 03; 13(7):1561-5. PubMed ID: 8875996
    [Abstract] [Full Text] [Related]

  • 7. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Prog Clin Biol Res; 1994 Oct 03; 385():43-9. PubMed ID: 7972236
    [Abstract] [Full Text] [Related]

  • 8. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J.
    Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876
    [Abstract] [Full Text] [Related]

  • 9. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
    Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Nat Genet; 1993 Jun 04; 4(2):191-4. PubMed ID: 8102299
    [Abstract] [Full Text] [Related]

  • 10. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I, Ellenbogen R, Jung WH, Vawter GF, Kretschmar C, Grier H, Korf BR.
    Cancer Res; 1990 Mar 01; 50(5):1459-63. PubMed ID: 2302711
    [Abstract] [Full Text] [Related]

  • 11. The DNA region around the c-myc gene and its amplification in human tumour cell lines.
    Feo S, Di Liegro C, Jones T, Read M, Fried M.
    Oncogene; 1994 Mar 01; 9(3):955-61. PubMed ID: 8108141
    [Abstract] [Full Text] [Related]

  • 12. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
    Corvi R, Savelyeva L, Schwab M.
    Cancer Res; 1995 Aug 15; 55(16):3471-4. PubMed ID: 7627947
    [Abstract] [Full Text] [Related]

  • 13. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 14. Structural features of the amplified N-myc oncogene detected by micrococcal nuclease digestion of neuroblastoma cell nuclei.
    Telford DJ, Stewart BW.
    Biochem Int; 1990 Sep 27; 21(6):1025-32. PubMed ID: 2080918
    [Abstract] [Full Text] [Related]

  • 15. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
    Chassevent A, Bénard J.
    Bull Cancer; 1997 Mar 27; 84(3):29-34. PubMed ID: 9207866
    [Abstract] [Full Text] [Related]

  • 16. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 17. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E, Hiyama K, Yokoyama T.
    Cancer Res; 1991 Apr 01; 51(7):1946-51. PubMed ID: 2004381
    [Abstract] [Full Text] [Related]

  • 18. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
    Noguchi T, Akiyama K, Yokoyama M, Kanda N, Matsunaga T, Nishi Y.
    Genes Chromosomes Cancer; 1996 Feb 01; 15(2):129-33. PubMed ID: 8834177
    [Abstract] [Full Text] [Related]

  • 19. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G.
    Am J Pathol; 1993 Dec 01; 143(6):1543-50. PubMed ID: 8256847
    [Abstract] [Full Text] [Related]

  • 20. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL.
    Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.